Transaction · 0001193125-26-361096

Kirn David

Kirn David, SR, reported a transaction classified as exercise at 4D Molecular Therapeutics, Inc. involving 50000.000000 shares for an estimated $207000.00. Reported holdings after the transaction were 894895.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MSR
FDMT4D Molecular Therapeutics, Inc.
Estimated value$207kShares × reported price
Shares traded50.0k$4.14 per share
Holdings after894kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

FDMT price since this filing

Daily closing prices, with the filing date and available return windows
FDMT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -29.9%1w ago -25.0%1d ago -7.0%
Returns since7d -7.3%30d -3.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001193125-26-361096
Common Stock
Transaction date
Aug 19, 2026
Filed Aug 21, 2026, 08:06 PM · 2d delay
Shares
50,000 sh
$4.14 per share
Estimated value
$207k
Computed from shares × price
Holdings after
894,895 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2026.

  2. F2

    The transaction was executed in multiple trades in prices ranging from $14.91 to $15.84, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person…

  3. F3

    The transaction was executed in multiple trades in prices ranging from $15.97 to $16.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person…

  4. F4

    The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 6, 2025 (the "Vesting Commencement Date"), suc…

Original filing · 0001193125-26-361096
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

FDMT